Twenty genes that were commonly upregulated by NTX-301 in the three different CCLs were involved in immune activation, and these genes included known tumor suppressors such as BTG2 [26], ALOX5 [27], SOCS1 [28], and TP53INP1 [29] (Supplementary Figure S4). The gene discussed is BTG2; the disease is neoplasm.